Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCRP6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,406
Award facts
- Contract value 100% obligated
- $26,406.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26.4K to DMS Pharmaceutical Group Inc. for BOTOX 200 unit vials on December 12, 2025, with completion expected by January 6, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through a firm fixed-price contract structure with no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order represents work performed under DMS Pharmaceutical Group's broader indefinite delivery contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
The PPV-G GEN V contract, valued at $499.9 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within a $30.3 billion government-wide acquisition strategy designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. This delivery order for BOTAX falls within DMS Pharmaceutical Group's authorized scope to provide branded and generic prescription drugs, biologics, and medical consumables to support the medical supply needs of military healthcare operations globally. The company's established performance across numerous prior delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FCRP6?
SPE2DR26FCRP6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FCRP6 worth?
The government has obligated $26,406 on SPE2DR26FCRP6.
Is contract SPE2DR26FCRP6 an order under another contract?
Yes. SPE2DR26FCRP6 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRP6 competed?
The extent of competition for SPE2DR26FCRP6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award